We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 159.20
Bid: 159.00
Ask: 159.40
Change: 1.80 (1.14%)
Spread: 0.40 (0.252%)
Open: 157.60
High: 160.00
Low: 155.20
Prev. Close: 157.40
FORT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

27 Apr 2018 13:14

RNS Number : 4279M
Forterra plc
27 April 2018
 

27 April 2018

Forterra plc

PDMR Shareholdings

Forterra plc (the "Company") was notified on 26 April 2018 that on the same day Matthew Clay, Managing Director, Bespoke Products and Darren Rix, Strategy and Development Director both of whom are defined as Persons Discharging Management Responsibilities (PDMR's) exercised share options over the Company's ordinary shares of 1p each ("ordinary shares") granted under the Forterra Deferred Annual Bonus Plan.

The options were granted as nominal (1p) cost options although this sum was waived by the Company on exercise. The number of options exercised also includes a dividend equivalent in addition to the options initially granted in accordance with the rules of the scheme. On exercise, sufficient shares were immediately sold to cover tax, NI and transaction costs.

No new shares were issued in respect of these transactions with the shares being transferred to the individuals from the Forterra Employee Benefit Trust.

Name

Number of options exercised

Number of shares transferred to individual after paying tax, NI and transaction costs

Number of shares now beneficially held by individual

Matthew Clay

18,779

9,921

9,921

Darren Rix

11,768

6,217

6,217

 

 

Enquiries

 

Forterra plc:

+44 (0) 1604 707 600

Shatish Dasani (CFO)

Ben Guyatt (Company Secretary)

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain/Nick Hasell

 

Further information relating to the Company and its group can be found at www.forterraplc.co.uk.

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Matthew Clay

2.

Reason for the notification

a)

Position/status

Managing Director Bespoke Products (PDMR)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

5299007SD2PDQMKM5278

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BYYW3C20

b)

Nature of the transaction

(i) Acquisition of 18,779 shares in the Company following the vesting of an award granted under the DABP on 1 June 2016; and (ii) subsequent sale of 8,858 shares to cover PAYE/NI liabilities arising from such vesting. The remainder of the shares (9,921) are being retained

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

(i) Acquisition

Nil

18,779

(ii) Sale

£3.06

8,858

d)

Aggregated information

 

Transaction

Price(s)

Volume(s)

Total

 (i) Acquisition

Nil

18,779

Nil

 (ii) Sale

£3.06

8,858

£27,105.48

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Darren Rix

2.

Reason for the notification

a)

Position/status

Strategy and Development Director (PDMR)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

5299007SD2PDQMKM5278

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BYYW3C20

b)

Nature of the transaction

(i) Acquisition of 11,768 shares in the Company following the vesting of an award granted under the DABP on 1 June 2016; and (ii) subsequent sale of 5,551 shares to cover PAYE/NI liabilities arising from such vesting. The remainder of the shares (6,217) are being retained

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

(i) Acquisition

Nil

11,768

(ii) Sale

£3.06

5,551

d)

Aggregated information

 

Transaction

Price(s)

Volume(s)

Total

 (i) Acquisition

Nil

11,768

Nil

 (ii) Sale

£3.06

5,551

£16,986.06

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHPGUCGCUPRGPM
Date   Source Headline
15th Apr 20241:46 pmRNSAnnual Report & Accounts 2023 & Notice of AGM 2024
12th Apr 202412:09 pmRNSDirector/PDMR Shareholding
9th Apr 20244:22 pmRNSDirector/PDMR Shareholding
9th Apr 20244:19 pmRNSDirector/PDMR Shareholding
3rd Apr 20242:19 pmRNSDirector/PDMR Shareholding
27th Mar 20244:44 pmRNSDirector/PDMR Shareholding
25th Jan 202412:27 pmRNSDirector Declaration
24th Jan 20247:19 amRNSProgressive publish new research
24th Jan 20247:00 amRNS2023 Trading Update
23rd Jan 20247:00 amRNSHolding(s) in Company
8th Dec 20237:00 amRNSDirector Declaration
9th Nov 20237:00 amRNSAppointment of Joint Corporate Broker
20th Oct 20236:05 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSQ3 Trading Update
5th Oct 20235:04 pmRNSGrant of Options under 2023 SAYE Scheme
11th Sep 20237:00 amRNSHolding(s) in Company
1st Sep 20235:46 pmRNSHolding(s) in Company
23rd Aug 20233:59 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSSix months ended 30 June 2023
11th Jul 20237:00 amRNSPost close half year trading update
5th Jul 202312:39 pmRNSEmployee Benefit Trust Share Purchase
30th Jun 20231:51 pmRNSHolding(s) in Company
6th Jun 202312:57 pmRNSEmployee Benefit Trust Share Purchase
23rd May 20232:22 pmRNSAnnual General Meeting 2023 Results
18th May 202312:12 pmRNSProgressive publish new research
16th May 20237:00 amRNSPre-AGM trading update
5th May 20234:39 pmRNSDirector/PDMR Shareholding
4th May 20239:00 amRNSEmployee Benefit Trust Share Purchase
25th Apr 20237:00 amRNSNotification of Board Changes
11th Apr 20234:15 pmRNSPCA Shareholdings
4th Apr 20231:12 pmRNSEmployee Benefit Trust Share Purchase
3rd Apr 20232:03 pmRNSGrant under Performance Share Plan
29th Mar 202310:21 amRNSAnnual Report & Accounts 2022 & Notice of AGM 2023
16th Mar 20235:28 pmRNSGrant under Deferred Annual Bonus Plan
10th Mar 20239:18 amRNSProgressive publishes new research
9th Mar 20237:02 amRNSAppointment of Independent Non-Executive Director
9th Mar 20237:00 amRNSFull Year Results
3rd Mar 20232:18 pmRNSEmployee Benefit Trust Share Purchase
3rd Feb 202310:13 amRNSEmployee Benefit Trust Share Purchase
1st Feb 20238:18 amRNSDirector Declaration
25th Jan 20237:00 amRNSTrading Update
5th Jan 20233:12 pmRNSEmployee Benefit Trust Share Purchase
14th Dec 20225:10 pmRNSEmployee Benefit Trust Share Purchase
8th Dec 20227:00 amRNSHolding(s) in Company
2nd Dec 20224:10 pmRNSEmployee Benefit Trust Share Purchase
22nd Nov 20227:54 amRNSProgressive publishes new research
22nd Nov 20227:01 amRNSAppointment of Chief Executive Officer
22nd Nov 20227:00 amRNSTrading Update
4th Nov 20222:50 pmRNSEmployee Benefit Trust Share Purchase
2nd Nov 20228:45 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.